Andreas Fellgiebel Selected Research

agalsidase beta

1/2019

Low-dose agalsidase beta treatment in male pediatric patients with Fabry disease: A 5-year randomized controlled trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andreas Fellgiebel Research Topics

Disease

18	Alzheimer Disease (Alzheimer's Disease) 02/2020 - 08/2004
10	Dementia (Dementias) 01/2021 - 01/2007
8	Cognitive Dysfunction 01/2021 - 08/2004
3	Fabry Disease (Fabry's Disease) 01/2019 - 04/2007
2	Atrophy 03/2017 - 02/2015
2	Stroke (Strokes) 01/2011 - 10/2005
2	Ataxia (Dyssynergia) 03/2004 - 10/2003
2	Korsakoff Syndrome (Wernicke-Korsakoff Syndrome) 03/2004 - 10/2003
1	Tauopathies 01/2021
1	Psychomotor Agitation (Akathisia) 01/2019
1	Ambulatory Care Sensitive Conditions 01/2019
1	Fatigue 01/2019
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2019
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 06/2018
1	Amyloidosis 01/2015
1	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 01/2013
1	Major Depressive Disorder (Major Depressive Disorders) 12/2011
1	Temporal Lobe Epilepsy 03/2010
1	Seizures (Absence Seizure) 03/2010
1	Epilepsy (Aura) 03/2010
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 06/2008
1	Frontotemporal Dementia (Semantic Dementia) 01/2007
1	Schizophrenia (Dementia Praecox) 05/2006
1	Coma (Comas) 10/2005
1	Wallerian Degeneration 08/2005
1	Alcoholic Korsakoff Syndrome 03/2004

Drug/Important Bio-Agent (IBA)

7	Amyloid (Amyloid Fibrils)IBA 01/2021 - 03/2009
6	Glucose (Dextrose)FDA LinkGeneric 09/2011 - 10/2003
5	Proteins (Proteins, Gene)FDA Link 01/2019 - 08/2004
4	Pharmaceutical PreparationsIBA 01/2019 - 01/2007
4	tau Proteins (tau Protein)IBA 02/2012 - 08/2004
3	Amyloid beta-PeptidesIBA 01/2019 - 08/2005
3	Biomarkers (Surrogate Marker)IBA 11/2014 - 02/2012
2	Dopamine (Intropin)FDA LinkGeneric 01/2020 - 03/2010
2	Metalloproteases (Metalloproteinases)IBA 01/2019 - 11/2014
2	RetinoidsIBA 01/2019 - 11/2014
2	Acitretin FDA Link 01/2019 - 11/2014
2	Cholinergic Agents (Cholinergics)IBA 03/2017 - 01/2014
2	pleiotrophin (HARP)IBA 02/2015 - 02/2015
2	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 11/2014 - 03/2009
2	Threonine (L-Threonine)FDA Link 03/2009 - 08/2004
1	CholesterolIBA 02/2020
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 02/2020
1	Bupropion (Wellbutrin)FDA LinkGeneric 01/2020
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2020
1	agalsidase beta FDA Link 01/2019
1	belimumabIBA 01/2019
1	AntibodiesIBA 01/2019
1	AutoantibodiesIBA 01/2019
1	DNA (Deoxyribonucleic Acid)IBA 01/2019
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2019
1	Interleukin-6 (Interleukin 6)IBA 01/2019
1	Donepezil (Aricept)FDA LinkGeneric 06/2015
1	EsterasesIBA 06/2015
1	Acetylcholine (Acetylcholine Chloride)FDA Link 06/2015
1	florbetapirIBA 01/2015
1	DisintegrinsIBA 11/2014
1	Apolipoproteins E (ApoE)IBA 05/2014
1	ApolipoproteinsIBA 05/2014
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2013
1	Cerebrospinal Fluid ProteinsIBA 02/2012
1	benzoylamido- 4'- aminostilbene- 2,2'- disulfonate (BADS)IBA 01/2011
1	Dopamine Receptors (Dopamine Receptor)IBA 03/2010
1	Pilocarpine (Ocusert)FDA LinkGeneric 03/2010
1	LigandsIBA 03/2010
1	fallyprideIBA 03/2010
1	EnzymesIBA 04/2007
1	Aripiprazole (Abilify)FDA Link 01/2007
1	1-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride (DEP)IBA 05/2006
1	Free RadicalsIBA 08/2005
1	Thiamine (Aneurin)FDA Link 10/2003

Therapy/Procedure

4	Therapeutics 01/2021 - 04/2007
1	Music Therapy 01/2021
1	Ambulatory Care (Outpatient Care) 01/2019
1	Length of Stay 01/2019
1	Activities of Daily Living (ADL) 03/2017
1	Enzyme Replacement Therapy 01/2014
1	Occupational Therapy (Therapy, Occupational) 08/2011
1	Drug Therapy (Chemotherapy) 06/2008
1	Critical Care (Surgical Intensive Care) 10/2005